![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 9/16 | |
C12N 15/861 | |||
A61K 48/00 | |||
A61K 38/00 |
(11) | Number of the document | 2510091 |
(13) | Kind of document | T |
(96) | European patent application number | 10801023.2 |
Date of filing the European patent application | 2010-12-07 | |
(97) | Date of publication of the European application | 2012-10-17 |
(45) | Date of publication and mention of the grant of the patent | 2017-06-28 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2010/059204 |
Date | 2010-12-07 |
(87) | Number | WO 2011/071859 |
Date | 2011-06-16 |
(30) | Number | Date | Country code |
283696 P | 2009-12-08 | US |
(72) |
KOLESNICK, Richard, N., US
STANCEVIC, Branka, US
SADELAIN, Michel, US
FUKS, Zvi, US
VARDA-BLOOM, Nira, IL
HARATS, Dror, IL
|
(73) |
Vascular Biogenics Ltd.,
6 Jonathan Netanyahu Street, 60376 Or Yehuda,
IL
Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, US |
(54) | METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS |
METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS |